Infectious Disease Alert
RSSArticles
-
PANDAS: Examining the Evidence for Treatment Options
Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) is a proposed disorder first named in 1998 that has been the subject of controversy in the literature. Although the debate has waned somewhat in the United States, it remains a topic of discussion in many European medical journals. A recent systematic review found no evidence for antimicrobial or immunomodulatory treatment for this condition.
-
Antibiotic Cycling Is Not Useful for Reducing Antibiotic-resistant Gram-negative Pathogens in Patients Admitted to Intensive Care Units
A randomized study that included eight intensive care units in Europe found no reduction in mortality or carriage of antibiotic-resistant gram-negative pathogens with antibiotic cycling compared to antibiotic mixing.
-
Azithromycin Saves Lives in Africa
Approximately 200,000 preschool-aged children in communities in Malawi, Niger, and Tanzania were treated twice yearly with either azithromycin or placebo. Communities in which azithromycin was provided had 13.5% less all-cause mortality than did placebo-treated communities. In children 1 to 5 months of age, the mortality was 25% lower with azithromycin than with placebo.
-
Infectious Disease Alert Updates
Probiotics and Lactobacillemia; The Last Poliovirus Challenge
-
Prosthetic Valve Endocarditis Due to Candida
Prosthetic valve endocarditis due to Candida spp. is associated with high mortality, but is curable — or at least controllable.
-
HANDOC: Some Guidance on When to Order Echocardiograms in Patients With Streptococcal Bacteremia
Non-β-hemolytic streptococci (NBHS) are the most common cause of infective endocarditis. In this retrospective study of 399 patients with NBHS bacteremia, 26 patients had endocarditis. HANDOC score (heart murmur, aetiology by specific species of NBHS, number of positive blood cultures, duration of symptoms, only one species in blood culture, and community-acquired infection) was predictive of endocarditis vs. non-endocarditis bacteremia.
-
Tuberculosis in the United States in 2017
While the incidence of tuberculosis in the United States in 2017 was the lowest ever recorded, the current rate of decline would be required to almost double to reach the goal of elimination of the disease in this country by the year 2100.
-
Extended-pulsed Dosing of Fidaxomicin vs. Standard-dose Vancomycin for Clostridium difficile Infection
A randomized, controlled, open-label clinical trial conducted at 86 European hospitals that included adults aged 60 years or older found that extended-pulsed dosing of fidaxomicin was superior to standard-dose vancomycin for sustained cure of Clostridium difficile infection and resulted in fewer disease recurrences.
-
Dealing With Multidrug-resistant Organisms on a National Level: CDC Successes and Problems on the Horizon
CDC efforts, implemented at the local level, have been associated with a modest reduction in the incidences of Escherichia coli and Klebsiella pneumoniae with an ESBL phenotype and a more dramatic reduction in carbapenem-resistant Enterobacteriaceae.
-
Planes, Pathogens, and Passengers: Infection Risk During Commercial Air Travel
Although air travel has been linked to transmission of respiratory infections, the actual risk of becoming infected during air travel is low. The risk is greatest, though, when seated within about two seats/rows of a contagious individual. Walking around the cabin increases risk.